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A B S T R A C T
Tissue ﬁbrosis, an accumulation of extracellular matrix proteins such as collagen, accompanies cardiac ageing in
humans and this is linked to an increased risk of cardiac failure. The mechanisms driving age-related tissue
ﬁbrosis and cardiac dysfunction are unclear, yet clinically important. Drosophila is amenable to the study of
cardiac ageing as well as collagen deposition; however it is unclear whether collagen accumulates in the ageing
Drosophila heart.
This work examined collagen deposition and cardiac function in ageing Drosophila, in the context of reduced
expression of collagen-interacting protein SPARC (Secreted Protein Acidic and Rich in Cysteine) an evolutio-
narily conserved protein linked with ﬁbrosis. Heart function was measured using high frame rate videomicro-
scopy. Collagen deposition was monitored using a ﬂuorescently-tagged collagen IV reporter (encoded by the
Viking gene) and staining of the cardiac collagen, Pericardin.
The Drosophila heart accumulated collagen IV and Pericardin as ﬂies aged. Associated with this was a decline
in cardiac function. SPARC heterozygous ﬂies lived longer than controls and showed little to no age-related
cardiac dysfunction. As ﬂies of both genotypes aged, cardiac levels of collagen IV (Viking) and Pericardin in-
creased similarly. Over-expression of SPARC caused cardiomyopathy and increased Pericardin deposition.
The ﬁndings demonstrate that, like humans, the Drosophila heart develops a ﬁbrosis-like phenotype as it ages.
Although having no gross impact on collagen accumulation, reduced SPARC expression extended Drosophila
lifespan and cardiac health span. It is proposed that cardiac ﬁbrosis in humans may develop due to the activation
of conserved mechanisms and that SPARC may mediate cardiac ageing by mechanisms more subtle than gross
accumulation of collagen.
1. Introduction
Collagens are crucial for the development of form and function in
multicellular animals. In mammals, increased collagen deposition oc-
curs in response to injury as part of the tissue repair process (Wynn,
2008). Collagen accumulation in humans, typically referred to as tissue
ﬁbrosis, is a clinically important feature of chronic disease states as well
as ageing. In both humans and mammalian models, tissue ﬁbrosis is
linked to organ dysfunction and an increased risk of mortality. Under-
standing the molecular genetics of collagen deposition and ﬁbrosis is
therefore an important step towards developing anti-ﬁbrotic therapies.
Fibrosis-related proteins and the signalling pathways leading to ﬁbrosis
show a high degree of genetic and functional conservation in the animal
kingdom (Volk et al., 2014; Hartley et al., 2016; Sessions et al., 2016).
The fruit or vinegar ﬂy, Drosophila melanogaster expresses several col-
lagen genes, as well as matricellular proteins required for the assembly
of extracellular matrices (Yasothornsrikul et al., 1997; Martinek et al.,
2008). Collagens and associated matricellular proteins are important
mediators of cardiac development in Drosophila (Hartley et al., 2016;
Chartier et al., 2002; Drechsler et al., 2013). Despite Drosophila being
highly amenable to studies of age-related cardiac decline (Wessells
et al., 2004; Cannon et al., 2017; Klassen et al., 2017; Lee et al., 2010;
Nishimura et al., 2014; Monnier et al., 2012), there are currently no
studies examining collagen deposition in the ageing heart.
SPARC (Secreted Protein Acidic and Rich in Cysteine) is a well-
characterised collagen binding matricellular protein involved in tissue
ﬁbrosis (Weaver et al., 2008; Bradshaw, 2012). SPARC is evolutionarily
and functionally conserved and known to mediate collagen deposition
in Drosophila embryos (Martinek et al., 2008). SPARC expression is
increased in a number of clinically important settings and accumulates
(along with other extracellular matrix (ECM) proteins) in the ageing
mammalian heart (Bradshaw et al., 2010; de Castro Bras et al., 2014),
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suggesting it may play a role in cardiac dysfunction in human ageing.
Recent ﬁndings indicate that reduced SPARC expression can correct
cardiomyopathy in Drosophila (Hartley et al., 2016). In addition, re-
duced expression of the ECM proteins Laminin, Viking and Pericardin in
the Drosophila heart can impede age-related cardiac dysfunction
(Sessions et al., 2016). Despite this knowledge, there is no data on
whether ECM proteins accumulate within the ageing Drosophila heart.
Embryonic and larval development of Drosophila is dependent on
the expression of type-IV collagen α2 and α1 chains encoded by Viking
and Cg25C, as well as Multiplexin (an ortholog of human COL18A1) and
the heart speciﬁc type-IV-like collagen, Pericardin; the latter two pro-
teins being integral to cardiac development (Chartier et al., 2002;
Harpaz et al., 2013). Although Pericardin was initially described as a
matrix forming type-IV-like collagen, it also adopts prominent ﬁbre-like
structures and acts as a ‘tendenous’ bridge between the heart and alary
muscles. How these collagenous ﬁbres are formed and maintained re-
mains largely uncharacterised.
In humans and mammalian models, ﬁbrosis is regarded as an ac-
cumulation of extracellular matrix in a given tissue. Most attention has
focused on ﬁbril forming collagens, however ﬁbrosis is complex and
outcomes in terms of organ function are aﬀected not only by the gross
accumulation of collagen subtypes and other ECM proteins but also by
the ratios of diﬀerent collagens and ECM proteins (Karsdal et al., 2017).
Experimental evidence indicates that Drosophila may be a tractable
model with which to study the mechanisms leading to tissue ﬁbrosis in
humans. For example, an accumulation of collagen in and around
Drosophila adipocytes alters innate immunity (Zang et al., 2015)
whereas diet-dependent changes to Drosophila heart function are asso-
ciated with cardiac ﬁbrosis (Na et al., 2013). These ﬁndings make
Drosophila a valuable tool with which to understand and identify me-
chanisms regulating collagen deposition and its impact on organ func-
tion. Given that collagen turnover (i.e. the expression, deposition and
degradation of collagen) as well as the ageing process are evolutionarily
conserved, it was predicted that collagen may accumulate as part of the
ageing process in the Drosophila heart model and that SPARC may
mediate this process.
In this report we describe the accumulation of collagen in the ageing
Drosophila heart and show that this accompanies the well-described
age-dependent functional decline of the ﬂy's heart. It is also shown that
SPARC heterozygous ﬂies have a longer lifespan as well as extended
cardiac health span. Despite this, the accumulation of collagen around
the heart does not seem to be aﬀected by reduced SPARC expression;
whereas, SPARC over-expression led to cardiomyopathy and Pericardin
accumulation. The ﬁndings support the idea that age-related ﬁbrosis in
mammals is an evolutionarily conserved process which can be studied
in simpler, genetically tractable models.
2. Materials and methods
2.1. Stock chemicals and ﬂy husbandry
Picrosirius red and all stock chemicals were from Sigma (Poole,
Dorset, UK). The Canton Special, w1118, yw, SPARCMI00329 (with a MiMIC
insertion in the 5-prime region of the SPARC locus; described in
(Venken et al., 2011)) and Viking-GFP strains were obtained from the
Bloomington Drosophila Stock Centre. The Dorothy-Gal4 line was de-
scribed previously (Kimbrell et al., 2002) and is used to drive the ex-
pression of genes downstream of a UAS (upstream activation sequence)
element. The UAS-SPARC line was described in (Martinek et al., 2008).
Flies were reared and maintained on a standard cornmeal-yeast-agar
diet under 12 h:12 h light:dark cycles at 25 °C. SPARCMI00329 were
backcrossed to a yw background for> 6 generations and then out-
crossed once to the w1118 line to generate heterozygous ﬂies for phe-
notyping and lifespan studies.
2.2. Lifespan studies
Ten male or female ﬂies within 1 day of eclosion were collected and
transferred to fresh vials with standard diet. Five to ten vials per trial
were prepared. At least two trials were conducted for each genotype.
Vials were maintained on their side and ﬂies tipped to fresh food twice
per week for the duration of the lifespan studies. All vials were main-
tained under 12 h:12 h light:dark cycles at 25 °C. Lifespan data is pre-
sented as Kaplan-Meier plots as well as the mean of the median (the
point at which 50% of the population had died) and maximum lifespan
(± SEM).
2.3. Histochemistry, imaging and qPCR
Adult ﬂies were anaesthetised by brief exposure to CO2, hearts were
exposed by dissection and ﬁxed using 1% formaldehyde for 15 min.
Picrosirius red dye was then added for 5 min at ambient temperature
and rinsed from dissected hearts using acidiﬁed water (1% acetic acid
in water). Picrosirius red comprises sulphonic acid and stains the basic
amine residues of most proteins but preferentially stains collagens be-
cause of their abundance and the large number of glycine residues.
Colour phase images were captured on a Leica DMLB ﬁtted with a Leica
DC300 colour camera, images were taken using μManager software
(Edelstein et al., 2010). Pericardin was imaged after staining dissected
hearts with the mouse-anti Pericardin monoclonal antibody clone EC11
(Zaﬀran et al., 1995) (Developmental Studies Hybridoma Bank, Uni-
versity of Iowa) followed by a ﬂuorescently-tagged secondary antibody.
Fluorescence images were taken using a Zeiss LSM 710 confocal mi-
croscope and images quantiﬁed using ImageJ by drawing a line across a
region of interest and recoding the maximum ﬂuorescence signal.
2.4. Analysis of cardiac Pericardin
Hearts stained with anti-Pericardin antibodies were imaged by
confocal microscopy and z-projections of stacks analysed in ImageJ.
The same number of z-projected stacks was sued for each genotype and
age. All images were of the distal region of the heart comprising ap-
proximately 2/3 of the total heart, where the majority of anti-
Pericardin staining is found. Images were thresholded and the percen-
tage of Pericardin positive signal quantiﬁed as a percentage of the total
image. For measurement of Pericardin ﬁbre thickness, single confocal
image stacks were used and at least six ﬁbre measurements were taken
from four diﬀerent ﬂies. Data are presented as the mean ﬁbre thickness
(± SEM).
2.5. Heart function analysis
Adult ﬂies were anaesthetised by brief exposure to Triethylamine
vapour (20 μL of a 50% solution made in 50% ethanol/water, placed
into the underside of a ﬂy vial's cotton cap). Flies were dissected as
described previously (Catterson et al., 2013) and imaged using a Zeiss
Axiolab microscope ﬁtted with a water immersion 10× objective,
linked to a Myocam S (Ionoptix Ltd., Ireland) high speed video camera.
The beating heart was imaged for 10–20 s at 120 frames per second
(fps) and heart function analysed using SOHA (Fink et al., 2009). For
heart analysis involving SPARC over-expression, video capture was
performed with a Ximea XDi camera and a frame rate of 25 fps.
2.6. Western Blotting
For each lane 10 female hearts were harvested and directly lysed in
10 μL Ripa buﬀer (Sigma, Poole, UK). Polypeptides were separated on a
4–20% SDS-page gel and transferred to a PVDF membrane. The mem-
brane was then probed with anti-pericardin (DSHB, EC11) and anti-
actin (DSHB JLA20) antibodies followed by secondary antibodies con-
jugated to alkaline phosphatase. Secondary antibodies were detected
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using NBT (nitro-blue tetrazolium chloride) with BCIP (5-bromo-4-
chloro-3′-indolyphosphate p-toluidine salt).
2.7. Statistics
When two means were compared, an unpaired two-tailed student's t-
Test was applied to establish the P-value. When mean data for genotype
and age were compared in an experiment, two-way ANOVA was used.
Graphs show mean± SEM.
3. Results
3.1. Overall collagen and collagen-IV deposition increases in older ﬂies
To assess collagen deposition in the heart two approaches were
initially used. Firstly picrosirius red, a histochemical dye used widely to
quantify collagen in mammalian tissue section was used to stain the
heart of one-week and six-week-old wild type (Canton S) Drosophila.
The adult Drosophila heart exhibited extensive pink-red staining that
became more intense in older ﬂies (inset Fig. 1A and B). Quantiﬁcation
of the signal was not possible due to older ﬂies developing a red-brown
pigmentation in their cuticle which aﬀected colour-based image ana-
lysis. The second approach used ﬂies expressing a ﬂuorescently tagged
Fig. 1. The Viking-GFP signal accumulates at all regions of the ageing
heart.
(A and B) The heart of adult ﬂies expressing a Viking-GFP fusion
protein shows an increase of signal over six weeks. This insets show
the signal from the histological stain picrosirius red of similarly aged
Canton S wild type ﬂies. The Viking-GFP signal is increased at the
valve (arrows), conical chamber (arrowheads) and distal heart (as-
terisk); scale bar = 150 μm. Confocal images and quantiﬁed data of
the Viking-GFP signal at the distal heart (C, F and I), valves (D, G and
J) and longitudinal muscles of the conical chamber (E, H and K) of one
and six week old ﬂies. V = valves. Quantiﬁed data was obtained from
four to six individual ﬂies at each age. Mean ﬂuorescence is expressed
in arbitrary units± SEM. P values were determined by t-Test.
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collagen-IV protein encoded by the viking gene (Morin et al., 2001).
This reporter system has been used to visualise collagen-IV during
embryogenesis and egg morphogenesis and reliably reports Viking
protein distribution in basement membranes (Pastor-Pareja and Xu,
2011; Haigo and Bilder, 2011). In accordance with the picrosirius red
results, Viking-GFP ﬂuorescence was abundant along the heart of adult
ﬂies and particularly intense at the 1st, 2nd and 3rd valve pairs (arrow
denotes the 2nd valve pair in Fig. 1A), the distal heart (asterisks Fig. 1A
and B) and the longitudinal muscles, especially those overlying the
conical chamber (arrowheads, Fig. 1A and B). As for the picrosirius red
result, the Viking-GFP signal at the distal heart, valve and longitudinal
muscles (Fig. 1C–E) was markedly increased in older ﬂies (Figs. F–H).
Unlike the picrosirius red signal, the Viking-GFP ﬂuorescence signal
was amenable to quantiﬁcation and recorded as signiﬁcantly increasing
at the distal heart, valves and longitudinal muscles of one and six-week-
old ﬂies (Fig. 1I–K; P < 0.01). Additionally, valve cells exhibited age-
dependent remodelling (Supplemental Fig. S1). This change to valve
morphology in Drosophila does not appear to have been documented
before but may reﬂect the senescence-related changes known to occur
to human aortic valve leaﬂets (Collins et al., 2014).
3.2. Cardiac Pericardin accumulation
In addition to Collagen-IV quantiﬁcation, the level of Pericardin was
quantiﬁed in one and six-week old ﬂies (Fig. 2). Pericardin is a type-IV-
like collagen associated exclusively with the insect dorsal vessel
(Chartier et al., 2002). Hearts of w1118 ﬂies stained with antisera to
Pericardin exhibited a complex network of overlapping Pericardin ﬁ-
bres, which were especially concentrated at the distal heart region
(Fig. 2A) and between adjacent nephrocytes and the heart tube (not
shown). The immunoﬂuorescence signal for Pericardin in six week old
ﬂies was increased relative to younger, one week old ﬂies (Fig. 2B;
P < 0.01). Western blot analysis of total cell lysates from isolated
hearts conﬁrmed an increased level of cardiac Pericardin on older ﬂies
(Fig. 2C and D; P < 0.05). In addition, Pericardin ﬁbre thickness was
analysed in single confocal sections and also found to be greater in
older ﬂies (Fig. 2E–H; P < 0.05).
3.3. Reduced SPARC expression is associated with extended lifespan
It is well established that, like the mammalian heart, there is an age-
dependent decline in cardiac function in Drosophila (Wessells et al.,
2004). In addition, there is an association between increased Pericardin
deposition and abnormal cardiac function in a diet-induced Drosophila
cardiomyopathy model (Na et al., 2013). Recent evidence from the
Drosophila heart model indicates that SPARC mediates the development
of a cardiomyopathy caused by disruption of the ﬂy's kidney-like ne-
phrocytes (Hartley et al., 2016). As Drosophila and mammalian SPARC
are both involved in collagen deposition, we asked whether a hypo-
morphic allele of Drosophila SPARC may alter the age-dependent de-
cline in cardiac function, age-dependent collagen deposition in the ﬂy
heart or both.
The mutant SPARC allele is caused by a transgene insertion that
reduces the gene's expression by 60% in heterozygous ﬂies (Hartley
et al., 2016). Both female and male SPARC heterozygous ﬂies had ex-
tended lifespan compared to controls (Fig. 3). Maximum and median
lifespan for female SPARC heterozygotes were 72 days and 63 days,
nine and ﬁfteen days longer than control's (Fig. 3B & C; P < 0.01).
Similarly, the maximum and median lifespan of male SPARC hetero-
zygous ﬂies were 66 days and 52 days; nine and ten days longer than
controls (Fig. 3E & F; P < 0.01).
3.4. Impact of reduced SPARC expression on the age-dependent decline of
heart function
To establish if SPARC mediated the age-dependent decline of car-
diac function, heart function was monitored at one, three and six weeks
in control and SPARC heterozygous ﬂies (Fig. 4). The cardiac function
of control ﬂies (w1118) exhibited an age-dependent decline as expected,
whereas SPARC heterozygous ﬂies showed no apparent change to
Fig. 2. Pericardin levels increase in the ageing heart.
(A) Confocal micrographs of z-projected stacks through the distal region of the hearts in ﬂies of diﬀerent ages stained with antisera to Pericardin. (B) The amount of Pericardin
ﬂuorescence signal in 1 wk and 6 wk-old ﬂies; n = 3; *P < 0.01. (C) Western blot of whole cell lysate of hearts from young (1 week) and older ﬂies (6 weeks) stained with antibodies
raised to Pericardin. Actin was used as a loading control. (D) Quantiﬁcation of polypeptide band intensity relative to the control (Actin). Data are the mean (± SEM) of measurements
from three independent experiments; *P < 0.05. (E–G) A single confocal slice through the distal region of the heart of young (1 week) and older ﬂies (6 weeks); scale bars = 100 μm in
E; 10 μm in F. Boxes depict examples of regions used for quantifying Pericardin ﬁbre thickness. (H) Pericardin ﬁbre thickness in young (1 week) and older ﬂies (6 weeks). Data are the
mean (± SEM) of ﬁbres from at least 6 ﬁbre measurements from four individual ﬂies at each age. *P < 0.01.
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Fig. 3. Extended lifespan in SPARC heterozygous ﬂies.
(A) Representative Kaplan-Meier plot of survival over time for ﬂies of the control (w1118, black line) and SPARC heterozygous genotypes (red line). Data is from females for each
genotype. (B & C) Quantiﬁed data for maximum and median lifespan. Data represents mean of two independent trials using ﬁve groups of 15 ﬂies of each genotype per trial. Data are
presented as the mean (± SEM) for each genotype. *P < 0.01.
Fig. 4. Extended cardiac health span in SPARC heterozygous ﬂies.
(A) The adult beating heart was imaged in semi-intact preparations and functional parameters measured from videos captured at ~120 frames per second. The m-modes show heart
contractions over a 12 s period. M-modes from two diﬀerent ﬂies of each genotype, control (w1118) and mutant (SPARCMI00329 heterozygotes) are show for each age (1 and 6 weeks old).
Older wild type ﬂies exhibit a disrupted heart rhythm, however this does not occur in SPARCMI00329 heterozygotes. (B) Quantiﬁed data for heart function showing that the age-dependent
decline in heart function recorded in the wild types (black lines) does not develop in SPARC+/− ﬂies (red lines). Graphs show mean± SEM for each parameter. *P < 0.001, there is an
age-related change in the parameter; #P < 0.01 there is a diﬀerence between genotypes by 2-way-ANOVA, n = 20–50 ﬂies per genotype, per time-point.
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cardiac function. Example m-modes (two-dimensional images of the
heart's contractions over time) show regular beating of the heart in
young (one week old control and SPARC heterozygous ﬂies; Fig. 4A).
There was a signiﬁcant change to the rhythmicity of cardiac contrac-
tions in six week old controls, characterised by a longer cardiac cycle
and periods of arrhythmia. This age-dependent change was not as ap-
parent in older SPARC heterozygous ﬂies (lower m-modes in Fig. 4A),
which exhibited cardiac function comparable to that of younger ﬂies.
Quantiﬁcation of heart rate, heart period, diastolic and systolic inter-
vals as well as the arrhythmia index (a measure of beat-to-beat varia-
bility) conﬁrmed there was an age-dependent change to all parameters
in controls but not SPARC heterozygous ﬂies (Fig. 4B; P < 0.01 for
age-dependent decline in controls; whereas there was no signiﬁcant
diﬀerence in SPARC heterozygous ﬂies as they aged). In terms of car-
diac morphology and contraction distance (FS, fractional shortening),
there was a small but signiﬁcant diﬀerence between the genotypes'
heart diameter at diastole (EDD) but not systole (ESD; Fig. 4B;
P < 0.01). However, neither genotype showed any age-related
changes to these three parameters (P < 0.05).
3.5. Over-expression of SPARC is suﬃcient to cause cardiomyopathy and
increase Pericardin deposition
To assess whether SPARC expression is suﬃcient to cause cardiac
dysfunction SPARC was over-expressed using Dorothy-Gal4 in peri-
cardial nephrocytes (large, kidney-like cells that lie adjacent to the
heart). Within one week of eclosion, cardiac function was severely
disrupted in ﬂies over-expressing SPARC. Heart dysfunction mirrored
the phenotype of older ﬂies, with the majority showing periods of ar-
rhythmia (71% of experimental ﬂies versus 0% of controls; Fig. 5A and
B) and a very slow heart rate (Fig. 5C; P < 0.01). Pericardial ne-
phrocytes are also a major source of Pericardin, and over-expression of
SPARC in the nephrocytes caused a signiﬁcant (~4-fold) increase to
Pericardin deposition around nephrocytes and the heart (Fig. 5D–F;
P < 0.01).
3.6. No evidence for reduced age-dependent collagen accumulation in
SPARC heterozygous ﬂies
The impact of SPARCmodulation on heart function was followed up
by an analysis of collagen deposition in one and six-week-old control
and SPARC heterozygous ﬂies. There was no apparent abnormality to
the ﬁbrous Pericardin network in SPARC heterozygous ﬂies compared
to controls, at either one or six weeks of age (Fig. 6A). Quantiﬁcation of
ﬁbre width in controls corroborated earlier ﬁndings, with older ﬂies
having thicker ﬁbres than younger ﬂies (Fig. 6B); however the same
was true for SPARC heterozygous ﬂies which also exhibited thicker
Pericardin ﬁbres in older ﬂies. Additionally, the Viking-GFP signal in
the heart valves of control and SPARC heterozygous ﬂies was similar at
all ages (1, 2, 4 and 6 weeks; Fig. 6C; P > 0.05). Finally, Pericardin
was quantiﬁed in young and old ﬂies by western blot and found to be
similar in young ﬂies of each genotype and to increase comparably in
both genotypes (Fig. 6D–F).
4. Discussion
This study examined collagen deposition in the ageing Drosophila
heart. This was done using a well-known histological stain that detects
collagen (picrosirius red), a collagen-IV reporter fusion protein (Viking-
GFP) and immunological detection of the type-IV-like collagen,
Pericardin. The work tested the hypothesis that age-related changes to
either cardiac function or cardiac collagen accumulation may be
mediated by the matricellular protein, SPARC. There was evidence for
increased collagen deposition in the heart that accompanied cardiac
dysfunction. Age-dependent cardiac dysfunction was prevented in
SPARC heterozygous ﬂies, however there was no evidence of reduced
collagen accumulation. SPARC over-expression was suﬃcient to cause
cardiomyopathy in young ﬂies and this accompanied increased
Pericardin deposition. We conclude that the Drosophila heart develops a
ﬁbrosis-like phenotype as it ages and that SPARC mediates cardiac
ageing and Pericardin accumulation. These ﬁndings suggest the ex-
istence of evolutionarily-conserved mechanisms of age-related collagen
deposition and that the Drosophila model may contribute to the study of
age-related ﬁbrosis in humans. However, it remains unclear how
SPARC and the accumulation of collagen are linked to cardiac dys-
function in Drosophila.
Fibrosis can be regarded as an accumulation of extracellular matrix
(ECM) in a given tissue. In humans and mammalian models, ﬁbrosis
typically develops as part of a tissue repair process, chronic in-
ﬂammatory disease or ageing. Fibrotic outcomes in terms of organ
function appear to be determined not only by the gross accumulation of
ECM but also by the ratios of diﬀerent ECM proteins (Karsdal et al.,
2017). The fact that we observed thickening of Pericardin ﬁbres and an
accumulation of type-IV collagen is consistent with the development of
a ﬁbrosis-like phenotype in the ageing Drosophila heart.
Accompanying the ﬁbrosis-like phenotype was a decline of cardiac
function. Cardiac dysfunction in ageing was expected and reported
previously by others (Wessells et al., 2004; Kaushik et al., 2015). It is
known that collagen accumulates in the ageing mouse myocardium and
that this correlates with increased SPARC protein levels, as well as
cardiac stiﬀness (Bradshaw et al., 2010). These age-related changes to
collagen and cardiac stiﬀness are blunted in SPARC-null animals
(Bradshaw et al., 2010). Similarly, in mice heterozygous for SPARC,
collagen IV levels do not increase in ageing ventricles (de Castro Bras
et al., 2014). There is recent evidence that SPARC mediates the devel-
opment of cardiomyopathy in Drosophila (Hartley et al., 2016) and that
reduced expression of extracellular matrix (ECM) proteins can prevent
cardiac ageing in ﬂies (Sessions et al., 2016). In accordance with these
ﬁndings it was hypothesised that reduced SPARC expression may pre-
vent the age-related decline of cardiac function in Drosophila, possibly
by modulating ECM deposition.
Using video microscopy of semi-intact heart preparations, it was
found that reduced SPARC expression prevented the age-dependent
decline of cardiac function. In addition, SPARC heterozygous ﬂies had
extended median and maximal lifespan compared to controls. Hence,
reduced SPARC contributes to a longer life with an accompanying ex-
tension of cardiac health-span in Drosophila. In contrast, over-expres-
sion of SPARC in pericardial nephrocytes was suﬃcient to cause a se-
vere a cardiomyopathy in young ﬂies that reﬂected the phenotype of
the aged heart. This cardiomyopathy accompanied the accumulation of
Pericardin, indicating that increased SPARC expression can promote
Pericardin deposition in Drosophila.
In contrast to the prediction that reduced SPARC may mediate the
accumulation of cardiac collagen in ageing ﬂies and the over-expression
result, reduced SPARC expression was recorded as not having an impact
on the quantity of Viking or Pericardin deposited around the heart at
any age. Both control and SPARC heterozygous ﬂies had similar levels
of cardiac Viking or Pericardin at one and six weeks of age, hence both
genotypes accumulated the collagens at a similar rate as they aged. This
suggests that SPARC's impact on cardiac health-span may depend on
mechanisms distinct to collagen accumulation. However, this conclu-
sion is oﬀered tentatively because there is a wealth of data indicating
that SPARC mediates collagen assembly in other models (Camino et al.,
2008). Hence, it is not possible to conclude that gross accumulation of
collagen around the ageing heart was the reason for the decline in
cardiac function. One mechanism by which SPARC may aﬀect cardiac
ageing is by activation of the Integrin-Linked Kinase pathway (ILK). It is
known that mammalian SPARC directly interacts with β-1 integrin and
activates ILK signalling (Weaver et al., 2008). A recent study in Dro-
sophila established that ILK regulates cardiac ageing (Nishimura et al.,
2014). It is therefore plausible that reduced SPARCmay prevent cardiac
ageing by reducing cardiac ILK signalling. However, this problem may
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be somewhat intractable because earlier work demonstrated that car-
diac-restricted knock-down of SPARC has deleterious eﬀects on heart
development and function (Hartley et al., 2016). Additionally, the
glycation of collagen (the formation of cross-linkages between collagen
ﬁbres) increases as organisms age and this aﬀects basement membrane
ﬂexibility (Paul and Bailey, 1996). Future work will examine whether
such qualitative changes to collagens occur in ageing Drosophila model
and whether they impact cardiac function.
In summary, the ageing Drosophila heart develops a ﬁbrosis-like
phenotype typiﬁed by an accumulation of collagen-IV (Viking) and the
type-IV-like collagen, Pericardin. This is associated with age-dependent
decline in cardiac function. Whilst reduced SPARC can ameliorate the
decline of cardiac function it does so by a mechanism that appears in-
dependent of the gross changes to collagen accumulation measured in
this study. The ﬁndings imply that the Drosophila heart can be used to
model the genetic pathways contributing to age-dependent ﬁbrosis in
higher organisms, including humans.
Supplementary data to this article can be found online at https://
doi.org/10.1016/j.exger.2017.10.011.
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Fig. 5. Over-expression of SPARC causes cardiomyopathy and increased Pericardin deposition.
(A) M-modes showing the impact of SPARC over-expression on heart function at one week of age (from videos captured at 25 frames per second). (B) The percentage of hearts that were
arrhythmic in controls (‘C’, the UAS-SPARC parent line outcrossed to w1118) versus SPARC overexpression ﬂies (driven by the Dorothy enhancer; ‘UAS-SPARC’); n = 7–10 ﬂies for each
genotype. (C) Mean heart rate (± SEM) for the control and SPARC over-expression ﬂies at one week. n = 7 ﬂies for each genotype; *P < 0.01. (D) Confocal micrographs of adult 1 week
old hearts stained with wheat germ agglutinin (red, to highlight cell surfaces) and antibodies to Pericardin (cyan); scale bar = 100 μm. (E) Higher magniﬁcation of hearts stained with
WGA and Pericardin antibodies; scale bar = 50 μm. (F) Percentage coverage of heart staining positive for Pericardin (mean,± SEM); n = 5; *P < 0.01.
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Fig. 6. The levels of Viking and Pericardin in aged SPARC heterozygous hearts.
(A) Confocal slices through the distal region of the hearts of young (1 week) and older (6 week) control (w1118) and SPARC heterozygous ﬂies (SPARCMI00329) stained with antibodies to
Pericardin. (B) Mean (± SEM) Pericardin ﬁbre thickness in ﬂies of diﬀerent ages and genotype as described in the ﬁgure. ns = P > 0.05. n = 6 measurement from 4 four individual
ﬂies. (C) Mean (± SEM) of the Viking-GFP signal at the valves of ﬂies of diﬀerent ages and genotype (w1118, black lines and SPARCMI00329, red lines). ns= P > 0.05. n = 6–10 ﬂies of
each age and genotype. (D) Western blot of heart tissue stained with Pericardin antibodies and actin as a loading control. (E) Quantiﬁcation of anti-Pericardin western blot band intensity
using at one week of age; ns= not statistically diﬀerent from control. (F) Quantiﬁed data showing fold change in Pericardin band intensity; n = three blots; *P < 0.05 for there being a
diﬀerence in Pericardin at 6 weeks compared to 1 week.
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